Skip to content
10-Q

Quarterly Report

EMERGE HEALTH INTERNATIONAL INC

0001477932-19-005850

← back to feed
Filed
Oct 15, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Sep 27, 2019 23.37M sh
Capex Q3 2019 · Mar 31, 2019 −$8.28K
Capex restated Q3 2019 · Mar 31, 2018 −$28.33K
Cash And Equivalents Q3 2019 · Mar 31, 2019 $109.25K
Cash And Equivalents Q3 2019 · Jun 30, 2018 $61.87K
Cash And Equivalents Q3 2019 · Mar 31, 2018 $57.98K
Cash And Equivalents Q3 2019 · Jun 30, 2017 $67.85K
Stockholders Equity Q3 2019 · Mar 31, 2019 $794.55K
Stockholders Equity Q3 2019 · Jun 30, 2018 $790.68K
Stockholders Equity restated Q3 2019 · Mar 31, 2018 $854.7K
Stockholders Equity Q3 2019 · Jun 30, 2017 $960.81K
Current Liabilities Q3 2019 · Mar 31, 2019 $345.8K
Current Liabilities Q3 2019 · Jun 30, 2018 $343.79K
Total Liabilities Q3 2019 · Mar 31, 2019 $424.39K
Total Liabilities Q3 2019 · Jun 30, 2018 $376.14K
Current Assets Q3 2019 · Mar 31, 2019 $774.95K
Current Assets Q3 2019 · Jun 30, 2018 $745.37K
Total Assets Q3 2019 · Mar 31, 2019 $1.22M
Total Assets Q3 2019 · Jun 30, 2018 $1.17M
Eps Basic Q3 2019 · Mar 31, 2019 −$0.01
Eps Basic Q3 2019 · Mar 31, 2019 $0.01
Eps Basic Q3 2019 · Mar 31, 2018 $0.00
Eps Basic Q3 2019 · Mar 31, 2018 −$0.02
Rd Expense Q3 2019 · Mar 31, 2019 $0
Rd Expense Q3 2019 · Mar 31, 2018 $0
Net Income Q3 2019 · Mar 31, 2019 −$230.14K
Net Income Q3 2019 · Mar 31, 2018 −$340.12K
Operating Income Q3 2019 · Mar 31, 2019 −$108.45K
Operating Income Q3 2019 · Mar 31, 2019 −$220.96K
Operating Income Q3 2019 · Mar 31, 2018 −$48.25K
Operating Income Q3 2019 · Mar 31, 2018 −$329.11K
Gross Profit Q3 2019 · Mar 31, 2019 $189.35K
Gross Profit Q3 2019 · Mar 31, 2019 $630.56K
Gross Profit Q3 2019 · Mar 31, 2018 $212.29K
Gross Profit Q3 2019 · Mar 31, 2018 $512.95K
Cost Of Revenue Q3 2019 · Mar 31, 2019 −$353.69K
Cost Of Revenue Q3 2019 · Mar 31, 2019 $1.13M
Cost Of Revenue restated Q3 2019 · Mar 31, 2018 −$151.18K
Cost Of Revenue restated Q3 2019 · Mar 31, 2018 −$931.24K
Revenue Q3 2019 · Mar 31, 2019 $543.03K
Revenue Q3 2019 · Mar 31, 2019 $1.76M
Revenue Q3 2019 · Mar 31, 2018 $363.47K
Revenue Q3 2019 · Mar 31, 2018 $1.44M